Navigation Links
Hanson Technologies, Inc. Awarded Patent for its Advanced Food Pathogen Detection System
Date:9/9/2009

CARLISLE, Pa., Sept. 9 /PRNewswire/ -- Hanson Technologies, Inc., an innovator in rapid biosensing solutions for food pathogen screening, today announced the issuance of a U.S. Patent entitled Agricultural Screening System and Method for Detection of Infectious Microorganisms. The U.S. patent describes the Company's method for screening for the presence of pathogenic microorganisms in vegetables, fruits, nuts and other plant material intended for human and animal consumption.

The Company's technology has the capability to screen entire lots of fresh produce with a 99.8% confidence versus less than 6% for conventional methods. In addition it provides results in 2 hours or less rather 12 to 36 hours providing significantly greater operational efficiency. The screening is the most comprehensive and fastest system solution available. The technology is incorporated into Hanson Technologies' OmniFresh(TM) 1000 System.

"The patent for rapidly identifying microorganisms that may be present in produce validates the superiority of our UltraRapid(TM) technology, and exemplifies our ground-breaking role in improved pathogen detection and greater freshness," said William P. Hanson, Ph.D., CEO of Hanson Technologies, Inc. "Our OmniFresh(TM) System stands alone in the market as the only solution capable of screening entire lots of large-volume produce. Hanson Technologies continues to be committed to preventing outbreaks from food-borne diseases such as Salmonella and E. Coli O157:H7."

OmniFresh(TM) 1000 screens entire lots of fresh produce in near-real time for contamination by E. coli O157:H7 and the capability to screen for additional bacteria including salmonella. It provides test results in two hours or less, compared to 12 to 36 hours for conventional lab testing methods that sample only a tiny percentage of produce lots. The OmniFresh(TM) 1000 System represents a significant improvement in pathogen screening, identifying 99.8%+ of typically contaminated produce lots vs. typically 1% to 5.8% using conventional testing methods.

The OmniFresh(TM) 1000 System is an automated, simple to use, integrated solution that is fully installed "in-line" with standard processing equipment. The system can be customized in various configurations to meet the specific screening needs of food growers and producers and screen large-volume batches in real-time.

According to the U.S. Food and Drug Administration, more than 5,000 people in the United States die each year from diseases caused by eating contaminated food. The economic cost of those incidents is more than $10 billion annually.

About Hanson Technologies, Inc.

Hanson Technologies is an innovator in food and water safety solutions. Hanson's technology solutions are based on a series of patented technologies. The firm's technology solutions have multiple applications including food safety testing, blood diagnostics and agricultural testing. To learn more about Hanson Technologies, please call 717-245-9890, or visit www.hansontechnologies.com.


'/>"/>
SOURCE Hanson Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009
2. Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009
3. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
4. Palatin Technologies, Inc. to Raise $3.1 Million in Registered Direct Offering
5. Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration
6. Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
7. OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
8. 4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.
9. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
10. Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.
11. Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... ... July 16, 2020 , ... ... in the early detection and prevention of high-burden diseases, and Centric Consulting, a ... and healthcare organizations to utilize existing data in order to identify and prioritize ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most ... used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate ... Dr MA has been using the zebrafish model to investigate the causes of ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... date growth of 40% in 2020, despite many obstacles created as a result ... to increase revenue for its partnered medical practices and medical manufacturers by expanding ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 ... or drug treatment. In an effort to better understand the cellular responses to ... largest imaging dataset portraying therapeutic compound effects from over 1,600 approved and referenced ...
Breaking Biology Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... ... completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the ... clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide customers ...
(Date:6/28/2020)... , ... June 25, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that it has entered ... innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... and software-driven clinical data services that accelerate drug development, is collaborating with Karyopharm ... XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the first study ...
Breaking Biology News(10 mins):